Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Elderly Metastatic Breast Cancer Population × pertuzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Stomach Neoplasms 1 Rectal Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Elderly Metastatic Breast Cancer Population 1 Colonic Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

pertuzumab 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01597414 2022-11-17

Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

Elderly Metastatic Breast Cancer Population

Data powered by HemOnc (CC BY 4.0) Colophon ⚡